Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LPAR1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | PRRC2C | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | FBXL4 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
mRNA | MOB3A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | AK7 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
mRNA | HHIPL1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
mRNA | CCDC88C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | CCNE2 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
mRNA | CHKB | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | CCDC58 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |